Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 19,652,000 | 20,272,000 | 20,314,000 | 20,317,000 | 18,312,000 |
| Cost of Goods | 8,296,000 | 9,216,000 | 9,607,000 | 9,665,000 | 8,797,000 |
| Gross Profit | 11,356,000 | 11,056,000 | 10,707,000 | 10,652,000 | 9,515,000 |
| Operating Expenses | 8,004,000 | 6,455,000 | 8,270,000 | 7,188,000 | 5,976,000 |
| Operating Income | 3,352,000 | 4,601,000 | 2,437,000 | 3,464,000 | 3,539,000 |
| Other Income | -1,121,000 | -968,000 | -1,227,000 | -1,691,000 | -644,000 |
| Pre-tax Income | 2,231,000 | 3,633,000 | 1,210,000 | 1,773,000 | 2,895,000 |
| Income Tax | 634,000 | 591,000 | -43,000 | -137,000 | 127,000 |
| Net Income Continuous | 1,597,000 | 3,042,000 | 1,253,000 | 1,910,000 | 2,768,000 |
| Minority Interests | 9,000 | -13,000 | -16,000 | -53,000 | 9,000 |
| Net Income | $1,588,000 | $3,055,000 | $1,269,000 | $1,963,000 | $2,759,000 |
| EPS Basic Total Ops | 1.84 | 3.58 | 1.49 | 2.25 | 3.10 |
| EPS Basic Continuous Ops | 1.87 | 3.57 | 1.48 | 2.19 | 3.11 |
| EPS Diluted Total Ops | 1.82 | 3.56 | 1.49 | 2.25 | 3.09 |
| EPS Diluted Continuous Ops | 1.85 | 3.55 | 1.47 | 2.19 | 3.10 |
| EBITDA(a) | $4,660,000 | $6,109,000 | $4,079,000 | $5,172,000 | $4,608,000 |